Company Search:
Advanced Search
Sponsored Links
Sinil Pharmaceutical Co Ltd Company Snapshot
Sinil Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sinil Pharmaceutical Co Ltd with three other companies in this sector in South Korea: Pharma Reaserch Products Co Ltd (2017 sales of 54.47 billion Korean Won [US$48.37 million] ), Humedix Co Ltd (54.73 billion Korean Won [US$48.60 million] ), and DHP Korea Co Ltd (49.81 billion Korean Won [US$44.23 million] ).

Sales Analysis. Sinil Pharmaceutical Co Ltd reported sales of 50.94 billion Korean Won (US$45.24 million) for the year ending December of 2017. This represents a very small increase of 1.5% versus 2016, when the company's sales were 50.21 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sinil Pharmaceutical Co Ltd
  Stock Performance Chart for Sinil Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 10,500
(Figures in Korean Won)
1 Week 1.9%   13 Weeks 4.5%  
4 Weeks 7.5%   52 Weeks -22.2%  
Sinil Pharmaceutical Co Ltd Key Data:
  Ticker: 012790 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 50,941,907,434
(Year Ending Jan 2018).
Employees: 361
  Currency: Korean Won Market Cap: 78,802,500,000
  Fiscal Yr Ends: December Shares Outstanding: 7,505,000
  Share Type: Common Closely Held Shares: 3,450,708
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.